×
About 1,544 results

ALLMedicine™ Prolactinoma Center

Research & Reviews  757 results

Multiple endocrine neoplasia type 1 with refractory hypoglycemia and lung and liver met...
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7809309
The Journal of International Medical Research; Wang Y, Zhang H

Jan 13th, 2021 - Multiple endocrine neoplasia type 1 (MEN1) is a rare autosomal dominant genetic disease. MEN1 with multiple endocrine adenomatosis complicated by multiple endocrine tumors is often misdiagnosed or missed. Herein, we describe the first reported cas...

Prolactinoma in childhood and adolescence-Tumour size at presentation predicts manageme...
https://doi.org/10.1111/cen.14394
Clinical Endocrinology; Arya VB, Aylwin SJB et. al.

Dec 19th, 2020 - To report the clinical presentation, management and outcomes of young patients with prolactinomas (<20 years) and conduct a systematic review and meta-analysis. Clinical, biochemical and radiological data (1996-2018) were collected from our centre...

Myasthenia gravis presenting as bilateral pseudointernuclear ophthalmoplegia in a patie...
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7747538
BMJ Case Reports; Arias Chavez JF, Fernandez CJ

Dec 18th, 2020 - Myasthenia gravis (MG) is a rare and potentially dangerous autoimmune condition, which affects the acetylcholine receptors at the neuromuscular junction of skeletal muscle. MG's diverse symptomatology may readily masquerade as other neurological c...

see more →

Clinicaltrials.gov  773 results

Multiple endocrine neoplasia type 1 with refractory hypoglycemia and lung and liver met...
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7809309
The Journal of International Medical Research; Wang Y, Zhang H

Jan 13th, 2021 - Multiple endocrine neoplasia type 1 (MEN1) is a rare autosomal dominant genetic disease. MEN1 with multiple endocrine adenomatosis complicated by multiple endocrine tumors is often misdiagnosed or missed. Herein, we describe the first reported cas...

Prolactinoma in childhood and adolescence-Tumour size at presentation predicts manageme...
https://doi.org/10.1111/cen.14394
Clinical Endocrinology; Arya VB, Aylwin SJB et. al.

Dec 19th, 2020 - To report the clinical presentation, management and outcomes of young patients with prolactinomas (<20 years) and conduct a systematic review and meta-analysis. Clinical, biochemical and radiological data (1996-2018) were collected from our centre...

Myasthenia gravis presenting as bilateral pseudointernuclear ophthalmoplegia in a patie...
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7747538
BMJ Case Reports; Arias Chavez JF, Fernandez CJ

Dec 18th, 2020 - Myasthenia gravis (MG) is a rare and potentially dangerous autoimmune condition, which affects the acetylcholine receptors at the neuromuscular junction of skeletal muscle. MG's diverse symptomatology may readily masquerade as other neurological c...

see more →

News  7 results

Prolactin, the pituitary, and pregnancy: Where’s the balance?
https://www.mdedge.com/familymedicine/article/164370/pituitary-thyroid-adrenal-disorders/prolactin-pituitary-and-pregnancy/page/0/3
Clinical Endocrinology News;

Apr 26th, 2018 - What if the tumor grows in pregnancy? During pregnancy, high estrogen levels from the placenta can stimulate prolactinoma growth, and the dopamine agonist’s inhibitory effect is gone once that medication’s been stopped. This means that “We have bo.

Pituitary Incidentaloma
https://www.mdedge.com/clinicianreviews/article/96669/endocrinology/pituitary-incidentaloma/page/0/1

Jan 26th, 2015 - SHOULD AN ASYMPTOMATIC PATIENT BE EVALUATED FURTHER? Endocrine Society guidelines2 recommend that all patients with pituitary incidentaloma, with or without symptoms, should undergo a complete history and physical examination and laboratory evalua.

Prolactinoma: A Case Study
https://www.mdedge.com/clinicianreviews/article/72153/endocrinology/prolactinoma-case-study/page/0/1

Nov 1st, 2011 - Dopamine agonists are approximately 80% to 90% effective in decreasing prolactin levels and reducing tumor size in microadenomas and 60% to 70% in macroadenomas. The major drawback of using medication is that it does not always provide permanent r.

Endocrine Society Releases Guidelines on Pituitary Incidentalomas
https://www.mdedge.com/internalmedicine/article/34059/endocrinology/endocrine-society-releases-guidelines-pituitary
Elizabeth Mechcatie

Apr 20th, 2011 - Surgical treatment of a pituitary incidentaloma is recommended when the lesion is causing a visual field deficit or other visual abnormalities, such as ophthalmoplegia "or neurological compromise," according to evidence-based clinical practice gui.

The Case of the Famous Woman With a Bloated Belly
https://www.medscape.com/viewarticle/714607_4

Jan 10th, 2010 - How Would Mary Have Been Treated Today? Today, when a woman suspects pregnancy, she undergoes a rapid test for pregnancy. If the result is negative but symptoms, such as galactorrhea or amenorrhea, are still present, an occult prolactinoma might b...

see more →

Patient Education  7 results see all →